JP2020518608A5 - - Google Patents

Download PDF

Info

Publication number
JP2020518608A5
JP2020518608A5 JP2019560139A JP2019560139A JP2020518608A5 JP 2020518608 A5 JP2020518608 A5 JP 2020518608A5 JP 2019560139 A JP2019560139 A JP 2019560139A JP 2019560139 A JP2019560139 A JP 2019560139A JP 2020518608 A5 JP2020518608 A5 JP 2020518608A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
busulfan
cyclodextrin
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019560139A
Other languages
English (en)
Japanese (ja)
Other versions
JP7204670B2 (ja
JP2020518608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/030728 external-priority patent/WO2018204535A1/en
Publication of JP2020518608A publication Critical patent/JP2020518608A/ja
Publication of JP2020518608A5 publication Critical patent/JP2020518608A5/ja
Priority to JP2022212559A priority Critical patent/JP7597778B2/ja
Application granted granted Critical
Publication of JP7204670B2 publication Critical patent/JP7204670B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019560139A 2017-05-03 2018-05-02 シクロデキストリン及びブスルファンを含有する組成物 Active JP7204670B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022212559A JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762500970P 2017-05-03 2017-05-03
US62/500,970 2017-05-03
PCT/US2018/030728 WO2018204535A1 (en) 2017-05-03 2018-05-02 Composition containing cyclodextrin and busulfan

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022212559A Division JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Publications (3)

Publication Number Publication Date
JP2020518608A JP2020518608A (ja) 2020-06-25
JP2020518608A5 true JP2020518608A5 (enExample) 2021-06-17
JP7204670B2 JP7204670B2 (ja) 2023-01-16

Family

ID=64014433

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019560139A Active JP7204670B2 (ja) 2017-05-03 2018-05-02 シクロデキストリン及びブスルファンを含有する組成物
JP2022212559A Active JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022212559A Active JP7597778B2 (ja) 2017-05-03 2022-12-28 シクロデキストリン及びブスルファンを含有する組成物

Country Status (10)

Country Link
US (2) US20180318249A1 (enExample)
EP (1) EP3618825A4 (enExample)
JP (2) JP7204670B2 (enExample)
KR (1) KR20190141244A (enExample)
CN (1) CN110831588B (enExample)
AU (1) AU2018263924B2 (enExample)
BR (1) BR112019023074A2 (enExample)
CA (1) CA3062308A1 (enExample)
MX (2) MX2019013053A (enExample)
WO (1) WO2018204535A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109078005B (zh) * 2018-08-07 2021-11-26 江苏领航生物科技有限公司 一种白消安组合物及其制备方法和应用
CN113679852B (zh) * 2021-09-13 2022-11-15 天津师范大学 一种水溶性主客体复合物及其制备与应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426011A (en) 1967-02-13 1969-02-04 Corn Products Co Cyclodextrins with anionic properties
US4783443A (en) 1986-03-03 1988-11-08 The University Of Chicago Amino acyl cephalosporin derivatives
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
US5241059A (en) 1990-05-21 1993-08-31 Toppan Printing Co., Ltd. Cyclodextrin derivatives
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5430057A (en) * 1993-09-30 1995-07-04 Board Of Regents, The University Of Texas System Parenteral busulfan for treatment of malignant disease
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US5874418A (en) 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
ATE323110T1 (de) 1997-07-01 2006-04-15 Pfizer Prod Inc Verfahren zur herstellung von einem cyclodextrin
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
CN1232539C (zh) 2002-05-10 2005-12-21 刘云清 有机药物与倍他环糊精衍生物的配合物及其制备方法
EP1543841A4 (en) 2002-08-15 2011-03-16 Yunqing Liu SOLID PHARMACEUTICAL NANO FORMULATION AND MANUFACTURING METHOD THEREFOR
WO2004024126A1 (en) 2002-09-13 2004-03-25 Cydex, Inc. Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin
JP2007523887A (ja) 2003-10-31 2007-08-23 ザ・ユニヴァーシティ・オブ・カンザス スルホアルキルエーテル−アルキルエーテルシクロデキストリン誘導体
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
ES2526903T3 (es) 2005-10-26 2015-01-16 Cydex Pharmaceuticals, Inc. Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
WO2007062403A2 (en) 2005-11-28 2007-05-31 Vernon D Rowe Compositions useful for reducing nephrotoxicity and methods of use thereof
US7658913B2 (en) * 2005-11-28 2010-02-09 Verrow Pharmaceuticals, Inc. Compositions useful for reducing nephrotoxicity and methods of use thereof
CN100411688C (zh) * 2006-09-12 2008-08-20 南京师范大学 含有环糊精/多烯紫杉醇包合物的药物组合物及其制备方法
AU2007325576B2 (en) 2006-10-20 2013-01-10 Icos Corporation Compositions of Chk1 inhibitors
CN102458114A (zh) * 2009-05-29 2012-05-16 锡德克斯药物公司 包含环糊精衍生物的可注射美法仑组合物及其制备和使用方法
HUE066956T2 (hu) * 2012-05-08 2024-09-28 Onyx Therapeutics Inc Peptid proteaszóma inhibitorok formulázására alkalmas ciklodextrin komplexálási eljárások
CN105726467A (zh) * 2014-12-09 2016-07-06 四川科瑞德制药有限公司 一种白消安注射液及其制备方法

Similar Documents

Publication Publication Date Title
JP6173502B2 (ja) 注射用徐放性製剤
JP2595458B2 (ja) タキサン類の誘導体を基とする新規組成物
JP4202273B2 (ja) フマギロール誘導体又はその塩の包接化合物、及び該包接化合物を含む医薬組成物
KR100330316B1 (ko) 탁산유도체를기재로한주사용조성물
JPWO2016035846A1 (ja) カテコール基を有するセファロスポリン類を含有する製剤
JP2002332234A (ja) ボリコナゾールを含有する薬剤製剤
JP2010528045A5 (enExample)
JP2014525449A5 (enExample)
JP2019514955A (ja) 選択的エストロゲン受容体ダウンレギュレーター(serds)
UA124818C2 (uk) Композиція для ін'єкції
CN1505513A (zh) 注射用西洛他唑水性制剂
JP2020518608A5 (enExample)
RU2008146217A (ru) Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование
JP6450356B2 (ja) 液状医薬製剤
RU2004133387A (ru) Фармацевтический препарат с немедленным высвобождением
KR101829685B1 (ko) 안정성 및 용해도가 개선된 주사용 조성물
JP7597778B2 (ja) シクロデキストリン及びブスルファンを含有する組成物
BR112013005763B1 (pt) Injeção de 5a-androstano-3ss, 5, 6ss-triol e método para prrparação da injeção
RU2678772C2 (ru) Композиция кабазитаксела
CN1931368A (zh) 含有环糊精紫杉醇包合物的药物组合物及其制备方法
RU2443432C2 (ru) Фармацевтическая композиция для введения инъекцией
TW201707707A (zh) 包含吲哚化合物之製劑及其製備方法
JP2022500350A (ja) 安定したアザシチジン含有医薬組成物の製造方法
JP6539671B2 (ja) フルラン複合体を製造するための方法
JP2014037377A (ja) 医薬製剤およびその製造方法